Lv3
308 积分 2024-04-06 加入
89 Zr/ 177 Lu-Labeled Radioimmunoconjugates Targeting SORT1 for Cancer Theranostics
12天前
已完结
Expression of the sortilin 1 receptor (SORT1) in healthy and tumor tissues
12天前
已完结
Expression of SORT1 in Gastric Cancer Tissue and Its Effect on Gastric Cancer Cell Biology
12天前
已完结
Exploring the role of ITGB6: fibrosis, cancer, and other diseases
23天前
已完结
PK/PD Evaluation of Antibody–Drug Conjugates with Enhanced Immune Effector Functions
30天前
已完结
Epidermal Growth Factor Receptor Expression and Gene Copy Number in Conventional Hepatocellular Carcinoma
1个月前
已完结
Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer
2个月前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
2个月前
已完结
Mechanistic insights into Wnt–β-catenin pathway activation and signal transduction
2个月前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
2个月前
已完结
皖公网安备34019202002308
